neurology 7th Congress of the European Academy of Neurology (EAN) - Virtual 2021 June 19-22, 2021 — Virtual Meeting STR1VE-EU: Gene Replacement Therapy in Symptomatic Spinal Muscular Atrophy Is Associated with Substantial Benefit Download 4 PowerPoint slides
neurology CURE SMA: Research and Clinical Care Meeting 2021 June 9-11, 2021 — Virtual Meeting Gene Therapy for Spinal Muscular Atrophy Effective as First- or Second-line Therapy Download 4 PowerPoint slides
neurology 7th Congress of the European Academy of Neurology (EAN) - Virtual 2021 June 19-22, 2021 — Virtual Meeting Head-to-Head Trial Shows Large Clinical Advantage for CGRP Monoclonal Antibody in Migraine Prophylaxis Download 3 PowerPoint slides
neurology American Headache Society (AHS) 2021: Expert Interview Dr. Jonathan P. Gladstone — Length: 06:32 HER-MES Trial Confirms Tolerability and Efficacy in Migraine Prevention Treatment Watch Presentation
neurology American Academy of Neurology (AAN) Annual Meeting 2021: Expert Interview Dr. Moogeh Baharnoori — Length: 05:08 Efficacy and Safety of a Targeted Therapy for Relapsing Multiple Sclerosis: An Analysis of the ASCLEPIOS Trials Watch Presentation
neurology American Academy of Neurology (AAN) Annual Meeting 2021 April 17-22, 2021 — Virtual Meeting Efficacy of Spinal Muscular Atrophy Therapies Depends on Early Initiation Download 5 PowerPoint slides
neurology American Academy of Neurology (AAN) Annual Meeting 2021: Expert Interview Dr. Douglas L. Arnold — Length: 03:36 MRI Measures and Cognitive Function in Persons with SPMS: New Findings from EXPAND Watch Presentation
Cardiology European Heart Rhythm Association (EHRA) 2021 Congress April 23-25, 2021 — Virtual Meeting ETNA-AF Registry: All Atrial Fibrillation Subgroups, Even the Old and Frail, Are Included in NOAC Benefit Download 2 PowerPoint slides
neurology Muscular Dystrophy Association (MDA) Conference 2021: Expert Interview Dr. Alex MacKenzie — Length: 07:02 Efficacy of SMN1 Gene Therapy in SMA: Clinical Takeaways from the SPR1NT Trial Watch Presentation
neurology Muscular Dystrophy Association (MDA) Clinical & Scientific Conference 2021 March 15-18, 2021 — Virtual Meeting Spinal Muscular Atrophy Remains Controlled in a Phase 3 Study with New Gene Therapy: SPR1NT Trial Download 4 PowerPoint slides
neurology Multiple Sclerosis: Expert Interview Dr. Sarah A. Morrow — Length: 03:48 Cognitive Function as a Therapeutic Target in SPMS Watch Presentation
neurology Multiple Sclerosis: Expert Review and Commentary from Published Literature Dr. Sarah A. Morrow Cognitive Function as an Endpoint in Secondary Progressive Multiple Sclerosis Download 4 PowerPoint slides